Physician profile
Meredith Watson
NPI 1598115511
$8,580.12
in general payments reported to CMS, 2019-2025
43 companies · $1,327 in 2025
The $1,327 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $339 · 2022: $1,593 · 2023: $2,646 · 2024: $2,674 · 2025: $1,327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,514 · Education: $74.54 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,513.83 |
| Education | $74.54 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,286.72 | 2021-2025 | Mounjaro, Jardiance, Trulicity |
| Novo Nordisk INC | $669.39 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Xeris Pharmaceuticals, INC. | $663.47 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Insulet Corporation | $490.62 | 2022-2025 | Omnipod |
| Ibsa Pharma INC. | $455.17 | 2022-2025 | Tirosint, Licart, Tirosint |
| Abbott Laboratories | $417.34 | 2021-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $377.73 | 2021-2025 | |
| Medtronic, INC. | $324.67 | 2023-2025 | Minimed 780g, Intellis Adaptivestim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $324.22 | 2021-2025 | Jardiance |
| Abbvie INC. | $319.28 | 2021-2024 | |
| Amneal Pharmaceuticals LLC | $305.32 | 2021-2025 | Unithroid |
| Amgen INC. | $302.69 | 2022-2025 | Tepezza, Repatha, Evenity |
| Tandem Diabetes Care, INC. | $244.69 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Mannkind Corporation | $213.27 | 2021-2023 | Afrezza |
| Beta Bionics, INC. | $211.81 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $193.36 | 2023-2025 | Isturisa, Signifor Lar |
| Antares Pharma, INC. | $176.75 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Cequr Corporation | $146.80 | 2022-2024 | Cequr Simplicity |
| Bayer Healthcare Pharmaceuticals INC. | $146.05 | 2022-2024 | |
| Ascensia Diabetes Care US INC. | $140.83 | 2023-2025 | |
| Lifescan, INC. | $130.02 | 2021-2023 | |
| Radius Health, INC. | $118.94 | 2021-2025 | |
| Ascendis Pharma Endocrinology INC | $118.76 | 2023-2025 | Yorvipath |
| Dexcom, INC. | $111.94 | 2022-2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $85.32 | 2022-2025 | Korlym |
| Pfizer INC. | $82.12 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $75.00 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $73.63 | 2022 | |
| Sequel Med Tech, LLC | $62.17 | 2025 | Twiist |
| Zealand Pharma US, INC. | $59.66 | 2021-2022 | |
| Kyowa Kirin, INC. | $26.46 | 2024 | Crysvita |
| Alexion Pharmaceuticals, INC. | $25.50 | 2025 | Strensiq |
| Chiesi USA, INC. | $25.12 | 2025 | Mycapssa |
| Neurocrine Biosciences, INC. | $24.48 | 2024 | Crenessity |
| Intuity Medical INC | $22.53 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Madrigal Pharmaceuticals | $21.80 | 2024 | Resmetirom |
| Amryt Pharma Holdings LTD | $20.06 | 2022 | |
| Halozyme INC | $16.45 | 2023 | |
| Azurity Pharmaceuticals, INC. | $15.16 | 2023 | Adthyza |
| Ultragenyx Pharmaceutical INC. | $14.75 | 2021 | |
| Merck Sharp & Dohme LLC | $14.25 | 2021 | |
| Becton, Dickinson and Company | $13.08 | 2022 | |
| Embecta Corp. | $12.74 | 2023 | Bd Nano 2nd Gen Pen Needle |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.